Hey everyone,
If you’ve seen our latest IMA review on psychedelic-assisted therapies for treatment-resistant depression, you know we’re diving deep into one of the most exciting—and sometimes controversial—frontiers in mental health care.
We’re seeing shifts in both clinical research and public policy around compounds like psilocybin, ketamine, MDMA, and more. There’s real scientific promise for people who haven’t had success with standard antidepressants, but there are also important questions about safety, long-term effects, and finding the right balance between enthusiasm and caution.
So the questions are—
* Have you or someone you know experienced these therapies?
* What do you think about psychedelics moving into mainstream mental health treatment?
* Do you see more hope, or more risk?
* What’s missing in the conversation?
We’d love to hear your thoughts, experiences, curiosities, or even skepticism. The more perspectives, the better the dialogue! And we can feed this back to the research team too.